The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association between locoregional failure and NFE2L2/KEAP1/CUL3 pathway mutations in NRG/RTOG 9512: A randomized trial of hyperfractionation vs. conventional fractionation in T2N0 glottic squamous cell carcinoma (SCC).
 
Li Guan
No Relationships to Disclose
 
Pedro A. Torres-Saavedra
No Relationships to Disclose
 
Xiaobei Zhao
No Relationships to Disclose
 
Michael B. Major
Honoraria - Vividion Therapeutics (Inst)
Research Funding - Vividion Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - patent US20220289686A1 for inhibitors of NRF2
 
Brittany J. Holmes
Consulting or Advisory Role - Ruby Robotics
 
Ngan Nguyen
No Relationships to Disclose
 
Parasakthy Kumaravelu
Stock and Other Ownership Interests - Atara Biotherapeutics; Oncology Pharma
 
Tim Hodge
Patents, Royalties, Other Intellectual Property - I hold a patent entitled "System and method for rapidly reporting testing results". Publication of US11361847B1 Although, I have acquired the patent I currently do not have any financial arrangement with any for-profit organization to utilize this technol
 
Maximilian Diehn
Leadership - Foresight Diagnostics
Stock and Other Ownership Interests - CiberMed; Foresight Diagnostics
Consulting or Advisory Role - AstraZeneca; BioNTech; Boehringer Ingelheim; Genentech; Gritstone Bio; Illumina; Novartis; Roche
Research Funding - AstraZeneca (Inst); Genentech (Inst); Illumina (Inst); Varian Medical Systems (Inst)
Patents, Royalties, Other Intellectual Property - Patent filings on ctDNA detection assigned to Stanford University (Inst); Patent filings on tumor treatment resistance mechanisms assigned to Stanford University (Inst)
 
Jose Zevallos
Leadership - Droplet Biosciences; Vine Medical
Stock and Other Ownership Interests - Droplet Biosciences
Consulting or Advisory Role - Merck; Vine Medical
Research Funding - Droplet Biosciences
Patents, Royalties, Other Intellectual Property - Droplet Biosciences; Vine Medical
Travel, Accommodations, Expenses - Medtronic
 
Bahman Emami
No Relationships to Disclose
 
Stephen M. Sagar
No Relationships to Disclose
 
William H. Morrison
Stock and Other Ownership Interests - Baxter; Becton Dickinson; Edwards Lifesciences; GE Healthcare; Johnson & Johnson/Janssen; Medtronic; Merck; Merck; Takeda
 
Christopher J. Schultz
Research Funding - Accuray (Inst); Elekta (Inst); Manteia (Inst); Philips Healthcare (Inst); Siemens (Inst)
Travel, Accommodations, Expenses - Elekta (Inst)
 
Jimmy J. Caudell
Research Funding - Varian Medical Systems
Patents, Royalties, Other Intellectual Property - UpToDate
 
Christopher U. Jones
No Relationships to Disclose
 
Sue S. Yom
Research Funding - Bristol-Myers Squibb (Inst); EMD Serono (Inst); Merck (Inst)
 
Jonathan Harris
No Relationships to Disclose
 
Quynh-Thu Le
Honoraria - Coherus Biosciences; Nanobiotix; Roche
Consulting or Advisory Role - Nanobiotix
 
David N. Hayes
Leadership - GeneCentric
Stock and Other Ownership Interests - GeneCentric
Consulting or Advisory Role - GeneCentric; Merck; Turnstone Bio
Patents, Royalties, Other Intellectual Property - I hold several diagnostic patents or pending patents in the area of solid tumor diagnostics